1. Home
  2. VIAV vs VERA Comparison

VIAV vs VERA Comparison

Compare VIAV & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • VERA
  • Stock Information
  • Founded
  • VIAV 1923
  • VERA 2016
  • Country
  • VIAV United States
  • VERA United States
  • Employees
  • VIAV N/A
  • VERA N/A
  • Industry
  • VIAV Semiconductors
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIAV Technology
  • VERA Health Care
  • Exchange
  • VIAV Nasdaq
  • VERA Nasdaq
  • Market Cap
  • VIAV 2.0B
  • VERA 1.6B
  • IPO Year
  • VIAV 1993
  • VERA 2021
  • Fundamental
  • Price
  • VIAV $9.11
  • VERA $18.95
  • Analyst Decision
  • VIAV Buy
  • VERA Buy
  • Analyst Count
  • VIAV 8
  • VERA 8
  • Target Price
  • VIAV $12.69
  • VERA $64.00
  • AVG Volume (30 Days)
  • VIAV 2.9M
  • VERA 1.3M
  • Earning Date
  • VIAV 05-01-2025
  • VERA 05-06-2025
  • Dividend Yield
  • VIAV N/A
  • VERA N/A
  • EPS Growth
  • VIAV N/A
  • VERA N/A
  • EPS
  • VIAV 0.02
  • VERA N/A
  • Revenue
  • VIAV $1,045,800,000.00
  • VERA N/A
  • Revenue This Year
  • VIAV $10.06
  • VERA N/A
  • Revenue Next Year
  • VIAV $7.08
  • VERA N/A
  • P/E Ratio
  • VIAV $398.76
  • VERA N/A
  • Revenue Growth
  • VIAV 3.34
  • VERA N/A
  • 52 Week Low
  • VIAV $6.60
  • VERA $18.53
  • 52 Week High
  • VIAV $12.91
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 36.85
  • VERA 35.84
  • Support Level
  • VIAV $8.92
  • VERA $18.76
  • Resistance Level
  • VIAV $9.36
  • VERA $20.21
  • Average True Range (ATR)
  • VIAV 0.21
  • VERA 0.90
  • MACD
  • VIAV 0.03
  • VERA -0.16
  • Stochastic Oscillator
  • VIAV 26.97
  • VERA 4.46

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: